Subject: S7-18-21: WebForm Comments from Zachary Kolansky
From: Zachary Kolansky
Affiliation: Tulane Medical School

Aug. 16, 2022



August 16, 2022

 I support transaction y transaction reporting. I'm particularly interested in how the same share can be relent multiple times, and how stocks in IRA accounts could be lent, devaluing the investment.

It is particularly concerning the Fidelity doesn't want short sale transparency, the implication of this is they lend out their clients shares to short sellers and devalue those investments.

I want to know who is lending shares, where those shares came from, and the aggregate short position on tickers. A little bit of short selling isn't a big deal, but a short hedgefund that is affiliated with a market maker is a gigantic conflict of interest. It is unlikely they are acting ethically, and are instead skirting the rules to make money. See Citadel's history of regulatory events.